[Federal Register Volume 75, Number 162 (Monday, August 23, 2010)]
[Notices]
[Page 51827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-20860]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of a Meeting of a Working Group of the NIH Advisory 
Committee to the Director

    The purpose of this notice is to inform the public about a meeting 
of the NIH Blue Ribbon Panel to Advise on the Risk Assessment of the 
National Emerging Infectious Diseases Laboratories (NEIDL) at Boston 
University Medical Campus.
    The meeting will be held Wednesday, September 22, 2010 at the Hyatt 
Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, MD 20814 from 
approximately 8:30 a.m. to 3:30 p.m.
    This meeting is the third in a series of public meetings between 
the Blue Ribbon Panel and the National Research Council Committee on 
Technical Input (NRC Committee) to review and discuss the ongoing 
supplementary risk assessment study being conducted for the Boston 
University NEIDL.
    The meeting will be open to the public, with attendance limited to 
space available. There will be a live webcast of the meeting which can 
be accessed at http://nihblueribbonpanel-bumc-neidl.od.nih.gov/. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the contact person listed below in advance of the meeting.
    Oral public comment will begin at approximately 3 p.m. Written 
comments may be provided, as well, by sending them to the address 
below. Written comments must be postmarked by October 1, 2010 and 
should include the name, address, telephone number and, when 
applicable, the business or professional affiliation of the commenter.
    A draft agenda and slides for the meeting may be obtained by 
connecting to http://nihblueribbonpanel-bumc-neidl.od.nih.gov/. For 
additional information concerning this meeting, contact Ms. Kelly 
Fennington, Senior Health Policy Analyst, Office of Biotechnology 
Activities, Office of Science Policy, Office of the Director, National 
Institutes of Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 
20892-7985; telephone 301-496-9838; e-mail [email protected].

    Dated: August 16, 2010.
Amy P. Patterson,
Acting Director, Office of Science Policy, National Institutes of 
Health.
[FR Doc. 2010-20860 Filed 8-20-10; 8:45 am]
BILLING CODE 4140-01-P